Aarti Pharmalabs Limited has announced the successful inauguration of Phase 1 of its greenfield manufacturing facility at Atali, District Bharuch, Gujarat. The company has received all necessary permissions and approvals to commence operations at the new site.
Phase 1 comes with a reactor capacity of 440 kL across 63 reactors. Spread over 80 acres of land, the site has been designed with future scalability in mind, capable of expanding up to 8–10 times its current capacity.
Commenting on the development, Mr. Rashesh Gogri, Chairman of Aarti Pharmalabs, said the inauguration of this seventh manufacturing site marks a significant step in the company’s growth trajectory. The new facility will serve as a key growth engine for the CDMO/CMO business, strengthen intermediates capacity, and contribute towards the company’s revenue goal of ₹1,000 crore from CDMO/CMO operations.
With state-of-the-art infrastructure, the Atali facility is set to enhance Aarti Pharmalabs’ product portfolio and serve global innovators and large pharmaceutical companies. The inauguration was attended by the Chairman, Managing Directors, senior management, and the Aarti Pharmalabs team, underscoring the company’s commitment to growth and specialized pharmaceutical solutions.
